Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merrymed Pharm is a South Korean pharmaceutical company primarily focused on the development, manufacturing, and distribution of ophthalmic and respiratory healthcare products. The company offers an extensive portfolio of eye drops and ointments targeting conditions such as glaucoma, dry eye, and ocular inflammation. In addition to its ophthalmic specialization, Merrymed Pharm produces a variety of internal medicines, including antibiotics, antitussives, and gastrointestinal treatments. The company aims to provide high-quality, affordable therapeutic solutions through its GMP-certified manufacturing processes and robust distribution network in Korea. Their products are widely utilized in clinical settings across South Korea, particularly in the field of ophthalmology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merrymed Farm.